Jiwen Liu

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 296 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

Prospective Cohort Study to Elucidate the Correlation between Occupational Stress and Hypertension Risk in Oil Workers from Kelamayi City in the Xinjiang Uygur Autonomous Region of China

Rong Li, Xiaoyan Gao, Bo Liu et al. · International Journal of Environmental Research and Public Health · 2016 · 248 citations · Full text

Public Health, Health Sciences, Preventive Medicine +16

Why Do SGLT2 Inhibitors Inhibit Only 30–50% of Renal Glucose Reabsorption in Humans?

Jiwen Liu, TaeWeon Lee, Ralph A. DeFronzo · Diabetes · 2012 · 221 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

miR-93-5p-Containing Exosomes Treatment Attenuates Acute Myocardial Infarction-Induced Myocardial Damage

Jiwen Liu, Mei Jiang, Shengqiong Deng et al. · Molecular Therapy — Nucleic Acids · 2018 · 201 citations · Full text

Life Sciences, Cardiology, Molecular Biology +16

Identification and Functional Characterization of Allosteric Agonists for the G Protein-Coupled Receptor FFA2

TaeWeon Lee, Ralf Schwandner, Gayathri Swaminath et al. · Molecular Pharmacology · 2008 · 155 citations

Life Sciences, Biochemistry, Pharmacology +17